Pyrrolizidine alkaloid-induced depletion of taurine from rat liver in vivo and in vitro

Advances in Experimental Medicine and Biology

Volumn 442, Issue , 1998, Pages 71-77

  Sun, Y ^a   Hasal, S J ^a   Yan, C C ^a   Brendel, K ^a   Huxtable, R J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRROLIZIDINE ALKALOID; TAURINE;

ALKYLATION; AMINO ACID METABOLISM; ANIMAL TISSUE; CONFERENCE PAPER; LIVER METABOLISM; LIVER TOXICITY; MALE; NONHUMAN; PLANT; PRIORITY JOURNAL; RAT; TOXIN ANALYSIS;

ANIMALIA;

EID: 0031863091     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-0117-0_9     Document Type: Conference Paper

References (40)

1. Adams, R. and Rogers, E.F., 1939, The structure of monocrotaline, the alkaloid in Crotalaria spectabilis and Crotalaria retusa, J. Amer. Chem. Soc., 61:2815-2819.
2. Azari, J., Brumbaugh, P., and Huxtable, R.J., 1980, Prophylaxis by taurine in the hearts of cardiomyopathic hamsters, J. Mol. Cell. Cardiol., 12:1353-1366.
3. Azuma, J., Sawamura, A., Awata, N., Ohta, H., Hamaguchi, T., Harada, H., Takihara, K., Hasegawa, H., Yamagami, T., Ishiyama, T., Iwata, H., and Kishimoto, S., 1985, Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial, Clin.Cardiol., 8:276-282.
4. Azuma, J., Takahisa, K., Awata, N., Ohta, H., Sawamura, A., Harada, H., and Kishimoto, S., 1984, Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits, Res. Comm. Chem. Pathol. Pharmacol. 45:261-270.
5. Banks, M.A., Porter, D.W., Martin, W.G., and Castranova, V., 1991, Ozone-induced lipid peroxidation and membrane leakage in isolated rat alveolar macrophages: Protective effects of taurine, J. Nutr. Biochem., 2:308-313.
6. Chauvin, P., Dillon, J.-C., Moren, A., Talbak, S., and Barakaev, S., 1993, Heliotrope poisoning in Tadjikistan, Lancet, 341:1663-1663.
7. Cooper, R.A. and Huxtable, R.J., 1996, A simple procedure for determining the aqueous half-lives of pyrrolic metabolites of pyrrolizidine alkaloids, Toxicon, 34:604-607.
8. Dokshina, G.A., Yartsev, E.I., Kolesnikov, Y.A., and Kostesha, N.Y., 1974, Influence of taurine on the recovery of tissue respiration and oxidative phosphorylation in liver mitochondria in irradiated rats, Radiology, 14:44-48.
9. Elizarova, E.P., Orlova, T.R., and Medvedeva, N.V., 1993, Effects on heart membranes after taurine treatment in rabbits with congestive heart failure, Arzneimittelforschung, 43:308-312.
10. 2-induced alterations, Am.J.Pathol., 125:585-600.
11. Huxtable, R., Stillman, A., and Ciaramitaro, D., 1977, Characterization of alkaloids involved in human senecio (pyrrolizidine) poisoning, Proc. Western Pharmacol. Soc., 20:455-459.
12. Huxtable, R.J., 1980, Herbal teas and toxins: novel aspects of pyrrolizidine poisoning in the United States, Perspect.Biol.Med., 24:1-14.
13. Huxtable, R.J., 1989, Human health implications of pyrrolizidine alkaloids and herbs containing them, in: "Toxicants of Plant Origin, Vol I: Alkaloids",. Cheeke, P.R., ed., CRC Press, Boca Raton, Florida, pp. 41-86.
14. Huxtable, R.J., 1997, Pyrrolizidine alkaloids, in: "Comprehensive Toxicology, Vol. 9. Hepatic and Gastrointestinal Toxicology", McCuskey, R.S. and Earnest, D.L., eds., Pergamon, pp. 423-431.
15. Huxtable, R.J., Paplanus, S., and Laugharn, J., 1977, The prevention of monocrotaline-induced right ventricular hypertrophy, Chest, 71S:308-310.
16. Izumi, K., Nagata, R., Motoya, T., Yamashita, J., Hirokane, T., Nagata, T., Satoh, Y., Sawada, Y., Ishibashi, M., Yoshida, H., and Fukuda, T., 1989, Preventive effect of taurine against acute paraquat intoxication in beagles, Jpn. J. Pharmacol., 50:229-233.
17. Kean, P.M. and Kay, J.M., 1965, Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension, Thorax, 40:159
18. Lehnert, B.E., Archuleta, D.C., Ellis, T., Session, W.S., Lehnert, N.M., Gurley, L.R., and Stavert, D.M., 1994, Lung injury following exposure of rats to relatively high mass concentrations of nitrogen dioxide, Toxicology, 89:239-277.
19. Mattocks, A.R., 1986. Chemistry and Toxicology of Pyrrolizidine Alkaloids. Academic Press, London.
20. Mattocks, A.R., Croswell, S., Jukes, R., and Huxtable, R.J., 1991, Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver, Toxicon, 29:409-415.
21. Mattocks, A.R. and White, I.N.H., 1973, Toxic effects and pyrrolic metabolites in the liver of young rats given the pyrrolizidine alkaloid retrorsine, Chem.Biol.Inter., 6:297-306.
22. Mayer, F. and Lüthy, J., 1993, Heliotrope poisoning in Tadjikistan, Lancet, 342:246-247.
23. Nakashima, T., Takino, T., and Kuriyama, K., 1982, Therapeutic effect of taurine administration on carbon tetrachloride-induced hepatic injury, Jpn. J. Pharmacol., 32:583-590.
24. Parrish, A.R., Gandolfi, A.J., and Brendel, K., 1995, Precision-cut tissue slices: Applications in pharmacology and toxicology, Life Sci., 21:1887-1991.
25. Robertson, K.A., 1982, Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, Cancer Res., 42:8-14.
26. Schoental, R., 1959, Liver lesions in young rats suckled by mothers treated with the pyrrolizidine (Senecio) alkaloids, lasiocarpine, and retrorsine, J.Path.Bact., 77:485-495.
27. Stillman, A.E., Huxtable, R., Consroe, P., Kohnen, P., and Smith, S., 1977, Hepatic veno-occlusive disease due to pyrrolizidine poisoning in Arizona, Gastroenterology, 73:349-352.
28. Stuart, K.L. and Bras, G., 1956, Veno-occlusive disease of the liver in Barbados, West Indian Med.J., 5:33-36.
29. Tandon, B.N., Tandon, R.K., Tandon, H.D., Narndranathan, M., and Joshi, Y.K., 1976, An epidemic of veno-occlusive disease of liver in central India, Lancet, ii:271-272.
30. Tandon, H.D., Tandon, B.N., and Mattocks, A.R., 1978, An epidemic of veno-occlusive disease of the liver in Afghanistan, Am.J.Gastroenterology, 70:607-613.
31. Venkatesan, N. and Chandrakasan, G., 1994, In vivo administration of taurine and niacin modulate cyclophosphamide- induced lung injury, Eur. J. Pharmacol. Environ. Toxicol. Pharmacol., 292:75-80.
32. Wang, Q., Giri, S.N., Hyde, D.M., and Li, C., 1991, Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin, Biochem. Pharmacol., 42:1115-1122.
33. Wang, Q., Giri, S.N., Hyde, D.M., and Nakashima, J.M., 1989, Effects of taurine on bleomycin-induced lung fibrosis in hamsters, Proc. Soc. Exp. Biol. Med., 190:330-338.
34. Yan, C.C. and Huxtable, R.J., 1994, Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline, Toxicol. Appl. Pharmacol., 127:58-63.
35. Yan, C.C. and Huxtable, R.J., 1995a, Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver, Life Sci., 57:617-626.
36. Yan, C.C. and Huxtable, R.J., 1995b, Effects of the pyrrolizidine alkaloid, retrorsine, on sulfur metabolism in the liver, Proc. Western Pharmacol. Soc., 38:37-40.
37. Yan, C.C. and Huxtable, R.J., 1995c, The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat, Toxicon, 33:627-634.
38. Yan, C.C. and Huxtable, R.J., 1996a, Effect of the pyrrolizidine alkaloid monocrotaline on taurine and sulfur amino acid metabolism in the rat liver, Adv. Exp. Med. Biol., 403:135-145.
39. Yan, C.C. and Huxtable, R.J., 1996b, Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat, Biochem. Pharmacol., 51:375-379.
40. Yan, C.C. and Huxtable, R.J., 1996c, Effects of taurine and guanidinoethane sulfonate on right ventricular hypertrophy induced by the pyrrolizidine alkaloid, monocrotaline, Biochem. Pharmacol., 51:321-329.